Parametric Portfolio Associates’s Immunomedics Inc IMMU Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q4
Sell
-248,322
Closed -$21.1M 4068
2020
Q3
$21.1M Buy
248,322
+14,511
+6% +$734K 0.02% 869
2020
Q2
$8.29M Buy
233,811
+48,677
+26% +$1.42M 0.01% 1531
2020
Q1
$2.5M Sell
185,134
-54,764
-23% -$921K ﹤0.01% 2238
2019
Q4
$5.08M Buy
239,898
+2,820
+1% +$49.7K ﹤0.01% 2057
2019
Q3
$3.14M Buy
237,078
+61,810
+35% +$909K ﹤0.01% 2357
2019
Q2
$2.43M Buy
175,268
+74,967
+75% +$1.13M ﹤0.01% 2532
2019
Q1
$1.93M Buy
100,301
+21,670
+28% +$349K ﹤0.01% 2687
2018
Q4
$1.12M Sell
78,631
-69,794
-47% -$1.39M ﹤0.01% 2915
2018
Q3
$3.09M Sell
148,425
-38,503
-21% -$912K ﹤0.01% 2392
2018
Q2
$4.42M Buy
186,928
+68,466
+58% +$1.38M ﹤0.01% 2057
2018
Q1
$1.73M Sell
118,462
-11,164
-9% -$182K ﹤0.01% 2710
2017
Q4
$2.1M Sell
129,626
-125,791
-49% -$1.48M ﹤0.01% 2572
2017
Q3
$3.57M Sell
255,417
-23,988
-9% -$239K ﹤0.01% 2145
2017
Q2
$2.47M Buy
279,405
+112,328
+67% +$789K ﹤0.01% 2376
2017
Q1
$1.08M Buy
167,077
+55,392
+50% +$281K ﹤0.01% 2822
2016
Q4
$410K Buy
111,685
+85,636
+329% +$253K ﹤0.01% 3287
2016
Q3
$85K Buy
26,049
+194
+0.8% +$542 ﹤0.01% 3698
2016
Q2
$60K Sell
25,855
-17
-0.1% -$57 ﹤0.01% 3770
2016
Q1
$65K Buy
25,872
+7,200
+39% +$16.2K ﹤0.01% 3910
2015
Q4
$57K Buy
18,672
+6,937
+59% +$19.4K ﹤0.01% 3906
2015
Q3
$20K Buy
+11,735
New +$30K ﹤0.01% 3255
2015
Q2
Sell
-40,319
Closed -$154K 4022
2015
Q1
$154K Hold
40,319
﹤0.01% 3809
2014
Q4
$194K Hold
40,319
﹤0.01% 3794
2014
Q3
$150K Buy
+40,319
New +$136K ﹤0.01% 3671

Parametric Portfolio Associates's IMMU Position: Q4 2020 in Review

Parametric Portfolio Associates sold out of Immunomedics Inc (IMMU) in Q4 2020, closing a stake of 248,322 shares — an estimated $21.1M sold.

Parametric Portfolio Associates first reported a position in IMMU in Q3 2014 and held it in 24 quarters. The position peaked at $21.1M in Q3 2020. 0 funds tracked by Wall St. Rank hold IMMU as of Q4 2020.

  • Parametric Portfolio Associates reported no remaining Immunomedics Inc position as of Q4 2020 after selling out during the quarter.
  • Parametric Portfolio Associates sold 248,322 Immunomedics Inc shares in Q4 2020, an estimated $21.1M.
  • Parametric Portfolio Associates first reported a position in Immunomedics Inc in Q3 2014 and held it in 24 quarters.
  • Parametric Portfolio Associates's Immunomedics Inc position peaked at $21.1M in Q3 2020.
  • 0 funds tracked by Wall St. Rank held Immunomedics Inc as of Q4 2020.

Based on Parametric Portfolio Associates's 13F filing for Q4 2020, filed 12 Feb 2021.